Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bath & Body Works, Inc.BBWI · Entity 4091 | Director | June 11, 2026 | June 15, 2026 |
| HERSHEY COHSY · Entity 795 | SVP, Chief Financial Officer | August 05, 2026 | August 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bath & Body Works, Inc.
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.50 par valueSEC Table I · non-derivative | Direct | 41,895 |
Reported balance
After 2026-06-11 transaction · row 1
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 7,970 · Balance 41,895 F1: Annual award of restricted stock units to independent non-employee directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual award of restricted stock units to independent non-employee directors.
HERSHEY CO
Report date August 05, 2026 · Filed August 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,245 |
Reported balance
After 2026-08-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-05 · Sale · Disposed 950 · Balance 52,245 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AVANOS MEDICAL, INC.
Report date May 03, 2018 · Filed May 07, 2019 · Amendment
Section 16 reporting ended · disclosed 2019-05-07. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $52.10 · Expires 2028-05-03 | Direct | 22,644 |
Reported balance
After 2018-05-03 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2018-05-03 · Grant · Acquired 22,644 · Balance 22,644 F1: This Form 4/A is being filed to correct the original Form 4 filed on 5/3/2018. That Form 4 reported the number of stock options as 33,966, but as described in detail in our Amended Proxy Statement dated 4/17/2019, the actual number of stock options that should have been issued is 22,644, and the Company has rescinded the excess 11,322 stock options incorrectly issued to Mr. Voskuil. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4/A is being filed to correct the original Form 4 filed on 5/3/2018. That Form 4 reported the number of stock options as 33,966, but as described in detail in our Amended Proxy Statement dated 4/17/2019, the actual number of stock options that should have been issued is 22,644, and the Company has rescinded the excess 11,322 stock options incorrectly issued to Mr. Voskuil.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 22, 2023 Filed Mar 23, 2023 20:17 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 471 | $242.74 | $114,330.54 |
DisclosureSEC source: 0001127602-23-011172 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,816 Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:46 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | GrantCommon Stock, $0.50 par value | 868 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003802 · doc4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 868 Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 21:16 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 752 | $239.22 | $179,893.44 |
DisclosureSEC source: 0001127602-23-007504 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,287 Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 21:12 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 548 | $240.47 | $131,777.56 |
DisclosureSEC source: 0001127602-23-007036 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,039 Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:16 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 6,362 | $240.90 | $1,532,605.80 |
DisclosureSEC source: 0001127602-23-006762 · form4.xml · nonDerivative · entry 2 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,587 Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:16 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 19,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006762 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,949 Read SEC document |
| July 11, 2022 Filed Jul 12, 2022 20:13 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 481 | $220.50 | $106,060.50 |
DisclosureSEC source: 0001127602-22-019230 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,925 Read SEC document |
| March 23, 2022 Filed Mar 24, 2022 20:48 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 548 | $207.76 | $113,852.48 |
DisclosureSEC source: 0001127602-22-010305 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,406 Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:24 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 751 | $204.32 | $153,444.32 |
DisclosureSEC source: 0001127602-22-007133 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,954 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:54 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 5,968 | $202.03 | $1,205,715.04 |
DisclosureSEC source: 0001127602-22-006640 · form4.xml · nonDerivative · entry 2 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,705 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:54 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 18,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006640 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,673 Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 17:48 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 2,364 | $176.82 | $418,002.48 |
DisclosureSEC source: 0001127602-21-021841 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,031 Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 13:24 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 597 | $157.04 | $93,752.88 |
DisclosureSEC source: 0001127602-21-012173 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,395 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 17:50 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 3,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007846 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,992 Read SEC document |
| August 10, 2020 Filed Aug 11, 2020 17:07 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 1,946 | $143.92 | $280,068.32 |
DisclosureSEC source: 0001127602-20-023334 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,211 Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:38 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 5,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008150 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,157 Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 20:36 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 11,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-024390 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,976 Read SEC document |
| May 31, 2019 Filed May 31, 2019 16:59 UTC | HERSHEY CO HSY · Entity 795 | PurchaseCommon Stock | 1,000 | $129.14 | $129,140.00 |
DisclosureSEC source: 0001127602-19-020276 · form4.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:55 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 5,103 | $47.89 | $244,382.67 |
DisclosureSEC source: 0001606498-19-000019 · wf-form4_155180850145051.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,135 F1 · shares: On 3/1/2019, 5,125 shares were withheld for taxes, but this filing indicates 5,103 shares (22 less than actually withheld) to correct a discrepancy on a going-forward basis. Read SEC document |
| March 01, 2019 Filed May 7, 2019 21:20 UTC Amendment | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 14,344 | $47.89 | $686,934.16 |
DisclosureSEC source: 0001606498-19-000033 · wf-form4a_155726403626269.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,479 F1 · shares: This Form 4/A is being filed to correct the original Form 4 filed on 3/5/2019. That Form 4 reported the number of shares withheld for taxes, but did not report the number of shares acquired by the reporting person. The reporting person acquired 14,344 shares, and net of the shares withheld for taxes, beneficially owned 31,479 shares. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 20:35 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | PurchaseCommon Stock | 2,000 | $43.74 | $87,470.00 |
DisclosureSEC source: 0001606498-18-000076 · wf-form4_154343733500639.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,238 Read SEC document |
| May 03, 2018 Filed May 4, 2018 20:29 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 33,966 | $0.00 Strike: $52.10 | $0.00 |
DisclosureSEC source: 0001606498-18-000047 · wf-form4_152546574698278.xml · derivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,966 Underlying: Common Stock · 33,966 shares Expires 2028-05-03 F1 · derivative.exercise_date: The awards vest 30% on May 3, 2019, 30% on May 3, 2020, and 40% on May 3, 2021, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| May 03, 2018 Filed May 7, 2019 21:28 UTC Amendment | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock · Derivative | 22,644 | $0.00 Strike: $52.10 | $0.00 |
DisclosureSEC source: 0001606498-19-000034 · wf-form4a_155726447410998.xml · derivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,644 Underlying: Common Stock · 22,644 shares Expires 2028-05-03 F1 · shares: This Form 4/A is being filed to correct the original Form 4 filed on 5/3/2018. That Form 4 reported the number of stock options as 33,966, but as described in detail in our Amended Proxy Statement dated 4/17/2019, the actual number of stock options that should have been issued is 22,644, and the Company has rescinded the excess 11,322 stock options incorrectly issued to Mr. Voskuil. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 16:32 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | Tax withholdingCommon Stock | 2,460 | $45.67 | $112,348.20 |
DisclosureSEC source: 0001606498-17-000069 · wf-form4_151024510737551.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,238 Read SEC document |
| May 03, 2017 Filed May 5, 2017 20:38 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 35,915 | $0.00 Strike: $36.74 | $0.00 |
DisclosureSEC source: 0001606498-17-000034 · wf-form4_149401669308679.xml · derivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,915 Underlying: Common Stock · 35,915 shares Expires 2027-05-03 F1 · derivative.exercise_date: The awards vest 30% on May 3, 2018, 30% on May 3, 2019, and 40% on May 3, 2020, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| April 30, 2017 Filed May 3, 2017 22:54 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | Tax withholdingCommon Stock | 3,194 | $39.50 | $126,163.00 |
DisclosureSEC source: 0001606498-17-000026 · wf-form4_149385204299598.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,698 Read SEC document |
| May 01, 2016 Filed Jan 19, 2017 20:52 UTC Amendment | AVANOS MEDICAL, INC. HYH · Entity 28189 | Tax withholdingCommon Stock | 2,837 | $28.16 | $79,889.92 |
DisclosureSEC source: 0001606036-17-000014 · primary_doc.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,892 F1 · shares: Due to a calculation error, the original Form 4 filed on May 3, 2016 incorrectly reported the number of securities withheld. The value reflects the actual amount of securities withheld in the transaction. F2 · balance_after: The original Form 4 filed on May 3, 2016 is amended by this Form 4 amendment to reflect the correct number of shares beneficially owned by the Reporting Person after the transaction. Read SEC document |
| November 07, 2014 Filed Nov 23, 2016 17:39 UTC Amendment | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantCommon Stock | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-16-000092 · wf-form4a_147992276785628.xml · nonDerivative · entry 1 Voskuil Steven E · CIK 0001622634 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,350 F1 · shares: The original Form 4 filed on November 12, 2014 is amended by this Form 4 amendment to correctly reflect the number of shares of stock that was received by the Reporting Person from Kimberly-Clark Corporation in connection with the distribution of all of the outstanding shares of common stock of the Issuer by Kimberly-Clark Corporation. Specifically, the Reporting Person received 2,917 shares of stock in connection with the distribution which includes 22 shares of stock that was erroneously omitted from the original Form 4. No other changes have been made to the original Form 4. F1 · balance_after: The original Form 4 filed on November 12, 2014 is amended by this Form 4 amendment to correctly reflect the number of shares of stock that was received by the Reporting Person from Kimberly-Clark Corporation in connection with the distribution of all of the outstanding shares of common stock of the Issuer by Kimberly-Clark Corporation. Specifically, the Reporting Person received 2,917 shares of stock in connection with the distribution which includes 22 shares of stock that was erroneously omitted from the original Form 4. No other changes have been made to the original Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.